Acceleron Pharma Inc is a company in the U.S. stock market and it is a holding in 45 U.S.-traded ETFs. XLRN has around 4.0M shares in the U.S. ETF market. The largest ETF holder of XLRN is the iShares Russell 2000 ETF (IWM), with approximately 1.05M shares. Investors may also find of interest that the ETF with the largest allocation to XLRN stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 2.69%. On average, U.S. ETFs allocate 0.25% of XLRN to their portfolios.
Additionally, XLRN is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with XLRN as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 35.89%.